Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)

NCT00890994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-03-22

No results posted yet for this study

Summary

In this research study, the investigators are testing a new type of breast camera, called Molecular Breast Imaging, to see if it can find tumors in the subject's breast.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Dietlind L. Wahner-Roedler, MD · Mayo Clinic

Eligibility

Min Age
25 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-19
Primary Completion
2014-11-14
Completion
2016-11-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00890994 on ClinicalTrials.gov